Senti Biosciences Holdings, Inc. (SNTI) Free cash flow 2021–2025
Senti Biosciences Holdings, Inc. (SNTI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$43.6MFY2025 · since FY2021: -$40.2M → -$43.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$43.6M | -5.4% |
| FY2024 | -$41.4M | +35.7% |
| FY2023 | -$64.4M | +15.5% |
| FY2022 | -$76.3M | -89.8% |
| FY2021 | -$40.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net incomeSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating incomeSNTI Operating marginSNTI Operating cash flowSNTI Capital expendituresSNTI Return on equitySNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Total liabilitiesSNTI Shareholders’ equitySNTI overview →